Australian and New Zealand Journal of Psychiatry最新文献

{"title":"Using data linkage for mental health research in Australia.","authors":"Sue M Cotton, Jana M Menssink, Matthew Hamilton, Kate M Filia, Shu Mei Teo, Mengmeng Wang, Dan Zq Gan, Wenhua Yu, Amity Watson, Katrina Witt, Melissa Hasty, Carl Moller, Alison Yung, Caroline X Gao","doi":"10.1177/00048674251333574","DOIUrl":"10.1177/00048674251333574","url":null,"abstract":"<p><p>Data linkage is a powerful tool for understanding the multifaceted needs and priorities of mental health care from the perspective of users and providers. Its potential remains underutilised in Australian settings - the Productivity Commission Inquiry into Mental Health in 2020 highlighted a significant gap: routinely collected administrative data are seldom leveraged in mental health research and service evaluation. In this manuscript, we provide insights into how data linkage has been used in mental health research, the type of questions that can be addressed, the steps involved in conducting data linkage research and the benefits and limitations of the use of this methodology. We propose crucial recommendations for advancing this field including: enhancing education for stakeholders (including the public, data custodians, ethics committees and policy makers); fostering stronger collaborative relationships with individuals with lived experiences throughout the research journey; improving infrastructure and resources for data linkage activities and linking data across sectors to address complex meaningful research questions. Data linkage is not just a method but a critical strategy to transform mental health research and service evaluation, ensuring more informed, effective and holistic mental health care.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"588-601"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181650/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the use of ketamine in psychiatric practice.","authors":"Salam Hussain, Chris Gale, Shanthi Sarma, Jeremy Smith, Adam Bayes, Colleen Loo","doi":"10.1177/00048674251333577","DOIUrl":"10.1177/00048674251333577","url":null,"abstract":"<p><p>Professional practice guidelines for the use of ketamine in psychiatric practice have been developed by the Royal Australian and New Zealand College of Psychiatrists to provide guidance on the use of ketamine in clinical practice in Australia and Aotearoa New Zealand, based on scientific evidence and supplemented by expert clinical consensus. Articles and information were sourced from existing guidelines and published literature. The findings were then formulated into consensus-based recommendations and guidance by the authors. The guidelines were subjected to rigorous successive consultation within the Royal Australian and New Zealand College of Psychiatrists, involving the Section of Electroconvulsive Therapy and Neurostimulation Committee, its broader membership and expert committees. The guidelines are intended for psychiatrists and clinicians engaged in the use of ketamine therapy to facilitate best practice to optimise outcomes for patients. They strive to find the appropriate balance between promoting best evidence-based practice and acknowledging that evidence for ketamine use is continually evolving.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"576-587"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143964587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter to the Editor: Author reply to Letter to the Editor regarding 'Concerns over the process and outcomes of the review by the Royal Australian and New Zealand College of Psychiatrists into long-term psychodynamic psychotherapy'.","authors":"Steve Kisely, Gin Malhi","doi":"10.1177/00048674251332735","DOIUrl":"10.1177/00048674251332735","url":null,"abstract":"","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"652-653"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143961829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter to the editor: Serious concerns about 'Concerns over the process and outcomes of the review by the Royal Australian and New Zealand College of Psychiatrists into long-term psychodynamic psychotherapy'.","authors":"Patrick Luyten, Max Moser, Peter Fonagy","doi":"10.1177/00048674251321761","DOIUrl":"10.1177/00048674251321761","url":null,"abstract":"","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"651-652"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143603736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Characteristics of deaths related to lithium toxicity in Australia, 2000-2024.","authors":"Shane Darke, Johan Duflou, Amy Peacock, Jessy Lim, Alys Havard, Michael Farrell, Julia Lappin","doi":"10.1177/00048674251336037","DOIUrl":"10.1177/00048674251336037","url":null,"abstract":"<p><strong>Objectives: </strong>To determine: (1) the characteristics, clinical presentation and circumstances of death for deaths related to lithium toxicity in Australia, 2000-2024; (2) the toxicology of cases; and (3) the major autopsy findings.</p><p><strong>Methods: </strong>A retrospective study of all cases of death aged ⩾15 years associated with lithium toxicity in Australia, 2000-2024, retrieved from the National Coronial Information System.</p><p><strong>Results: </strong>We identified 93 cases, with a mean age of 48.7 years (range, 18-89), 12% being aged under 30 years and 51% being male. A diagnosis of bipolar disorder was documented in 52%, with 28% having a documented psychotic disorder. The circumstances of death were unintentional toxicity (58%), intentional toxicity (23%) and undetermined intent (19%). The median blood lithium concentration was 0.68 mmol/L (range, 0.01-17.3). Concentrations were higher for ante-mortem versus post-mortem samples (2.3 vs 0.5 mmol/L), intentional overdose versus unintentional (2.2 vs 0.5 mmol/L) and cases in which lithium was the sole drug detected versus multiple drugs (2.1 vs 0.6 mmol/L). Other drugs were present in the majority (87%), most commonly antipsychotics (67%) and antidepressants (57%). Cardiomegaly was diagnosed in 22% and nephro/arteriosclerosis in 26%.</p><p><strong>Discussion: </strong>Toxicity remains a rare event compared to exposure to lithium, with intentional cases comprising a fifth of the series. Deaths were not the sole preserve of the middle-aged or elderly.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"622-628"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The impact of COVID-19 on participation in Australia's National Bowel Cancer Screening Program by people with severe mental illness: A national data linkage study.","authors":"Claudia Bull, Katrina Spilsbury, David Lawrence, Karinna I Saxby, Steve Kisely","doi":"10.1177/00048674251336034","DOIUrl":"10.1177/00048674251336034","url":null,"abstract":"<p><strong>Objective: </strong>The impact of COVID-19 on Australia's National Bowel Cancer Screening Program remains unclear, especially for individuals with severe mental illness. These individuals have historically participated in the National Bowel Cancer Screening Program at significantly lower rates than the general population. This study aimed to understand the impact of COVID-19 on participation in Australia's National Bowel Cancer Screening Program among individuals with severe mental illness.</p><p><strong>Methods: </strong>Cohort study using deidentified linked health and National Bowel Cancer Screening Program data. We compared participation in the National Bowel Cancer Screening Program between individuals with and without severe mental illness by examining rates of participation (returning an immunochemical faecal occult blood test), returning a valid immunochemical faecal occult blood test, receiving a positive immunochemical faecal occult blood test result and undergoing a follow-up colonoscopy before (25 January 2018-24 January 2020) and during (25 January 2020-31 July 2021) the COVID-19 pandemic.</p><p><strong>Results: </strong>Overall National Bowel Cancer Screening Program participation fell by 10.3% from pre-COVID to during COVID. Less than one-quarter (23.9%) of people with severe mental illness participated in the National Bowel Cancer Screening Program during the COVID-19 pandemic compared to 30.5% before. People with severe mental illness were less likely to return a valid immunochemical faecal occult blood test and more likely to return a positive immunochemical faecal occult blood test result both before and during the pandemic, compared to the general population. They were also significantly less likely to have a colonoscopy following positive immunochemical faecal occult blood test result (pre-COVID adjusted relative risk = 0.97, 95% confidence interval: 0.94-1.01, vs during COVID adjusted relative risk = 0.87, 95% CI: 0.82-0.91).</p><p><strong>Conclusion: </strong>The pandemic significantly reduced the rate at which all Australians participated in the National Bowel Cancer Screening Program. Disparities between people with severe mental illness and the general population generally improved with the exception of follow-up colonoscopy after positive immunochemical faecal occult blood test result.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"640-650"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Increases in delivery of a brief smoking cessation intervention following implementation of a system change intervention in community psychiatry settings.","authors":"Sally Plever, Steve Kisely, Billie Bonevski, Irene McCarthy, Melissa Anzolin, Dan Siskind, Emma Ballard, Brett Emmerson, John Allan, Coral Gartner","doi":"10.1177/00048674251340214","DOIUrl":"10.1177/00048674251340214","url":null,"abstract":"<p><strong>Objective: </strong>Tobacco-related disease is a leading cause of premature mortality for people experiencing mental illness. Tobacco treatment is not routinely provided in psychiatry with systemic barriers preventing access to treatment. This study examines a system change approach, with an incentive payment, to implement tobacco treatment at scale in community psychiatry settings.</p><p><strong>Methods: </strong>Secondary analysis of statewide health administrative data was conducted. Changes in documentation of smoking status and delivery of a tobacco treatment brief intervention (the Pathway) were evaluated using interrupted time series analysis between July 2017 and June 2023. An implementation period (4 years), divided into incentive payment phases for achievement of pre-defined targets, and a post-incentive payment maintenance period (2 years) were defined.</p><p><strong>Results: </strong>Documented average smoking rate for community psychiatry during maintenance remained high (52.5%; 95% confidence interval = [52.5, 52.6]). Statewide documentation of smoking status significantly exceeded targets during implementation, reaching 93.9% (95% confidence interval = [93.3%, 94.4%]). Despite a 2.1% decrease (95% confidence interval = [-3.4, -0.8]) after removal of incentive payments, reporting remained high 91.9% (95% confidence interval = [91.5%, 92.3%]). Documentation of the Pathway was significantly higher than targets and showed no change by implementation end (87.0%; 95% confidence interval = [85.9%, 88.1%]) to maintenance where no incentive payments were available (85.7%; 95% confidence interval = [84.9%, 86.5%]).</p><p><strong>Conclusions: </strong>Delivery of tobacco treatment in psychiatry is an important step to addressing inequity in smoking prevalence, but achieving this has been challenging. Our study demonstrates the potential of a system change intervention to improve care and sustainably deliver tobacco cessation treatment, at scale, in psychiatry settings.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"602-611"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144109484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Where next for cognitive remediation in Australasian mental health care?","authors":"Susan L Rossell, K Allott, S Bryce, K Douglas, A Miles, M Thomas, T E van Rheenen, F Dark","doi":"10.1177/00048674251333567","DOIUrl":"10.1177/00048674251333567","url":null,"abstract":"","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"573-575"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143964607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mental health and self-harm/suicide risk screening at prison entry over 12 months in a total population sample in New South Wales, Australia.","authors":"Carey Marr, Christie Browne, Dylan Ngui, Reem Zeki, Emma Woods, Kimberlie Dean","doi":"10.1177/00048674251336031","DOIUrl":"10.1177/00048674251336031","url":null,"abstract":"<p><strong>Introduction: </strong>International research has found high rates of mental illness and self-harm/suicide among people in prison. However, existing studies are often limited by their sample selection methodology, and many do not examine mental health at prison entry specifically. In addition, with smaller samples, previous studies have lacked statistical power to robustly examine and compare subgroups.</p><p><strong>Method: </strong>This study examines a total population sample of 9568 individuals entering public prisons in New South Wales, Australia over a 1-year period, and describes the prevalence of a range of mental health and self-harm/suicide risk indicators collected during routine health screening upon prison entry.</p><p><strong>Results: </strong>In total, 62% of prison entrants reported a lifetime mental health condition and 23% reported a serious mental illness. Lifetime self-harm (14%) and suicide attempts (12%) were also high. Women and First Nations people entering prison had higher prevalence of most mental health diagnoses and of previous self-harm and suicidal ideation/behaviour than men and non-First Nations people.</p><p><strong>Conclusion: </strong>These results establish the scale of mental health need and self-harm/suicide risk among people entering prison, particularly among women and First Nations people. There is a clear need for investment to adequately resource prison-based mental health services to meet the needs of prison entrants, but also in interventions to prevent those with significant mental health needs from entering prison in the first place. These strategies may include targeted and preventive approaches via mental health diversion and community-based mental health services.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"629-639"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181648/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Understanding the onset and remission of suicidal thoughts in Australian men: Findings from the Ten to Men study.","authors":"Tilahun Haregu, Gregory Armstrong","doi":"10.1177/00048674251333572","DOIUrl":"10.1177/00048674251333572","url":null,"abstract":"<p><strong>Introduction: </strong>While Australian studies explore suicidal thoughts' prevalence and correlates, little is known about their first onset in unaffected individuals or the predictors and rates of remission in the general population.</p><p><strong>Objective: </strong>The objective of the study is to determine the rates of first-onset suicidal thought and remission of suicidal thoughts among Australian males over a 9-year period and to identify predictors of these rates.</p><p><strong>Methods: </strong>This retrospective cohort study analysed 6035 participants from the Ten to Men study over four waves spanning 9 years. Outcomes included the first onset and remission of suicidal thoughts, with predictors encompassing sociodemographic, lifestyle, substance use, mental health and social factors. Modified Poisson regression with robust errors was used to identify predictors.</p><p><strong>Results: </strong>The rate of first-onset suicidal thoughts over the 9-year study period was 19.2% (95% confidence interval = [18.1%, 20.4%]). The remission rate for suicidal thoughts over the same period was 65.5% (95% confidence interval = [62.5%, 68.4%]). The onset of suicidal thoughts was linked to lower education, depressive symptoms, disability, financial stress, homosexual orientation and history of partner violence. Depressive symptoms and disability were also associated with reduced remission rates.</p><p><strong>Conclusion: </strong>One-fifth of males reported a first onset of suicidal thoughts, while nearly two-thirds with a history of such thoughts experienced remission over the 9-year period. Suicide prevention interventions need to prioritize males with a disability and mental health problems, as these factors both predict the first onset of suicidal ideation and reduce the rate of remission.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"612-621"},"PeriodicalIF":4.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143962975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}